1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): : initial results from an international prospective study
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
(
- Contribution to journal › Article
- 2004
-
Mark
Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin
(
- Contribution to journal › Article
- 1993
-
Mark
Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer
(
- Contribution to journal › Article
- 1991
-
Mark
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
(
- Contribution to journal › Article
- 1990
-
Mark
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma
(
- Contribution to journal › Article